253 related articles for article (PubMed ID: 21752341)
1. Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum.
Orrú M; Quiroz C; Guitart X; Ferré S
Neuropharmacology; 2011; 61(5-6):967-74. PubMed ID: 21752341
[TBL] [Abstract][Full Text] [Related]
2. Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.
Orrú M; Zanoveli JM; Quiroz C; Nguyen HP; Guitart X; Ferré S
Exp Neurol; 2011 Nov; 232(1):76-80. PubMed ID: 21867705
[TBL] [Abstract][Full Text] [Related]
3. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.
Chiodi V; Ferrante A; Ferraro L; Potenza RL; Armida M; Beggiato S; Pèzzola A; Bader M; Fuxe K; Popoli P; Domenici MR
J Neurochem; 2016 Mar; 136(5):907-17. PubMed ID: 26526685
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission.
Quiroz C; Pearson V; Gulyani S; Allen R; Earley C; Ferré S
Exp Neurol; 2010 Jul; 224(1):292-8. PubMed ID: 20385128
[TBL] [Abstract][Full Text] [Related]
5. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
[TBL] [Abstract][Full Text] [Related]
6. Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists.
Orru M; Bakešová J; Brugarolas M; Quiroz C; Beaumont V; Goldberg SR; Lluís C; Cortés A; Franco R; Casadó V; Canela EI; Ferré S
PLoS One; 2011 Jan; 6(1):e16088. PubMed ID: 21264319
[TBL] [Abstract][Full Text] [Related]
7. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
Pinna A; Bonaventura J; Farré D; Sánchez M; Simola N; Mallol J; Lluís C; Costa G; Baqi Y; Müller CE; Cortés A; McCormick P; Canela EI; Martínez-Pinilla E; Lanciego JL; Casadó V; Armentero MT; Franco R
Exp Neurol; 2014 Mar; 253():180-91. PubMed ID: 24412491
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function.
Ferré S; Quiroz C; Orru M; Guitart X; Navarro G; Cortés A; Casadó V; Canela EI; Lluis C; Franco R
Front Neuroanat; 2011; 5():36. PubMed ID: 21731559
[TBL] [Abstract][Full Text] [Related]
9. Behavioral control by striatal adenosine A
Taura J; Valle-León M; Sahlholm K; Watanabe M; Van Craenenbroeck K; Fernández-Dueñas V; Ferré S; Ciruela F
Genes Brain Behav; 2018 Apr; 17(4):e12432. PubMed ID: 29053217
[TBL] [Abstract][Full Text] [Related]
10. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum.
Rodrigues RJ; Alfaro TM; Rebola N; Oliveira CR; Cunha RA
J Neurochem; 2005 Feb; 92(3):433-41. PubMed ID: 15659214
[TBL] [Abstract][Full Text] [Related]
11. L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.
Bonaventura J; Rico AJ; Moreno E; Sierra S; Sánchez M; Luquin N; Farré D; Müller CE; Martínez-Pinilla E; Cortés A; Mallol J; Armentero MT; Pinna A; Canela EI; Lluís C; McCormick PJ; Lanciego JL; Casadó V; Franco R
Neuropharmacology; 2014 Apr; 79():90-100. PubMed ID: 24230991
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A(2A)-cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission.
Tebano MT; Martire A; Popoli P
Brain Res; 2012 Oct; 1476():108-18. PubMed ID: 22565012
[TBL] [Abstract][Full Text] [Related]
13. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.
Garção P; Szabó EC; Wopereis S; Castro AA; Tomé ÂR; Prediger RD; Cunha RA; Agostinho P; Köfalvi A
Br J Pharmacol; 2013 Aug; 169(7):1600-11. PubMed ID: 23638679
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists.
Lerner TN; Horne EA; Stella N; Kreitzer AC
J Neurosci; 2010 Feb; 30(6):2160-4. PubMed ID: 20147543
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.
Tebano MT; Martire A; Chiodi V; Pepponi R; Ferrante A; Domenici MR; Frank C; Chen JF; Ledent C; Popoli P
J Neurochem; 2009 Sep; 110(6):1921-30. PubMed ID: 19627447
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-cannabinoid receptor interactions. Implications for striatal function.
Ferré S; Lluís C; Justinova Z; Quiroz C; Orru M; Navarro G; Canela EI; Franco R; Goldberg SR
Br J Pharmacol; 2010 Jun; 160(3):443-53. PubMed ID: 20590556
[TBL] [Abstract][Full Text] [Related]
18. Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.
Martire A; Tebano MT; Chiodi V; Ferreira SG; Cunha RA; Köfalvi A; Popoli P
J Neurochem; 2011 Jan; 116(2):273-80. PubMed ID: 21062287
[TBL] [Abstract][Full Text] [Related]
19. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G; Lovinger DM
J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
[TBL] [Abstract][Full Text] [Related]
20. Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function.
Rosin DL; Hettinger BD; Lee A; Linden J
Neurology; 2003 Dec; 61(11 Suppl 6):S12-8. PubMed ID: 14663003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
